Effectively Bringing Fixed Dose Combination Products to Market to Maintain Growth and... ( CHAPEL HILL N.C. March 8 2013 /PR...)

Effectively Bringing Fixed Dose Combination Products to Market to Maintain Growth and Pipelines

Date:3/8/2013

CHAPEL HILL, N.C., March 8, 2013 /PRNewswire/ -- The pharmaceutical industry has turned to sustainable growth opportunities to address the pipeline and patent challenges facing many organizations in the sector. One opportunity for growth lies in extending a product's patent life by combining branded products.

Fixed dose combination (FDC) products have clinical and commercial advantages. For the drug manufacturer, an FDC product can extend the therapeutic advantage and becomes part of lifecycle management. For the patient, FDC products can address unmet medical needs and reduce pill burdens.

But there is more to success than just developing a new FDC and launching it. Successful research and development leaders recognize that understanding the market and audience will smooth the FDC launch process, according to a study by benchmarking leader Best Practices, LLC.

"Fixed Dose Combination Products: Successful Strategies for Developing and Bringing FDC Products to Market" identifies successful strategies and innovative practices for developing and bringing FDC products to market. Through executive insights and advice, the study also addresses the pitfalls and obstacles to avoid in this work.

A third of the FDC leaders who participated in the study said the most important lesson learned from their work with FDC products is the need to focus on the differentiated benefit and value that the product can bring to patients, physicians and payers.

Some of the issues addressed in this research include:

Chief reason for pursuing FDC development
Measures used to evaluate success
Years from decision to develop through launch
Cost of FDC product development
Time lapsed from initial contact to signed contractual agreement with
'/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Ensuring Pharmaceutical Organizations are Effectively Organizing and Deploying Medical Science Liaisons across Diverse Customer Groups
2. Louisiana Pain Specialist Dr. Arnold Feldman Uses Advanced Techniques to Effectively Treat Herniated Disc
3. Effectively Using Communication Channels and Tools to Reach Core Decision Makers in Organizations Across all Business Sectors
4. Positioning Strategies Effectively Minimize Cannibalization of a Legacy Brand When Expanding a Product Portfolio
5. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
6. For Drug Manufacturers Bringing a New Product to Market, Gaining the Support of Influential Doctors Is a Mission-Critical Priority
7. Clinical Site Services Is Bringing 3x More Patient Enrollment to the 48th Annual DIA Meeting
8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
9. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
10. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
11. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone

Post Your Comments:

(Date:5/22/2013)... 22, 2013 STEPh, Inc., a full service ... of their web site ( http://www.stephreports.com ) ... About STEPh Reports STEPh Reports are ... Each STEPh Report assesses the competitive landscape by ... year, company, and specific key issues. STEPh Reports are ...

(Date:5/22/2013)... May 22, 2013 Upsher-Smith Laboratories, ... of its global Phase III clinical trial ... program for the management of epilepsy in ... USL255 is specifically engineered to provide convenient ... blood levels observed with currently available treatment ...

(Date:5/22/2013)... 22, 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) ... about some recent company developments. As Medifirst continues to ... communication with shareholders. Integrating social media into its investor ... and will post updates on Twitter. The Facebook homepage ... Says CEO Bruce J. ...

Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4 Medifirst Solutions, Inc. Announces Update To Shareholders 2

[0] Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site [0] Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures [0] Medifirst Solutions, Inc. Announces Update To Shareholders

... CARSON CITY, Nev., Dec. 21, 2011 Denali Concrete ... has commenced patient enrollment for a phase 3 clinical ... administered orally, in patients with moderate-to-severe Dry Eye Syndrome. ... States, Europe and Israel. The randomized, double-masked clinical trial ...

... and BEDMINSTER, N.J., Dec. 20, 2011 QRxPharma Limited (ASX: QRX ... of Intent (LOI) with Actavis Inc. for the formation of ... acute pain marketplace. MoxDuo IR is a patented ... Inc. is a subsidiary of Actavis Group, hf a privately ...

Cached Medicine Technology:Denali Concrete Management Inc. Announces the Commencement of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study 2 QRxPharma Announces Strategic Partnership with Actavis 2 QRxPharma Announces Strategic Partnership with Actavis 3 QRxPharma Announces Strategic Partnership with Actavis 4 QRxPharma Announces Strategic Partnership with Actavis 5

Denali Concrete Management Inc. Announces the Commencement of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study QRxPharma Announces Strategic Partnership with Actavis

(Date:5/22/2013)... Francisco, CA (PRWEB) May 22, 2013 On ... costing $6,500 or more on average, a funeral concierge can ... funeral, among other benefits. Funeral Financials announces ... the average household income in the U.S. having ... according to Sentier Research, the average funeral costs 12.6% of ...

(Date:5/22/2013)... TWITTER: @the_USO & @SesameStreet are proud to ... in the next 6 months! , Today, the ... came together to show their heartfelt thanks to those who currently ... for distribution to our servicemen and women. The group was ... and the USO as well as the success of the ...

(Date:5/22/2013)... 22, 2013 Zensah® Compression Apparel released ... article titled "Breast pain while running affects ... could help." According to the article, a British ... substantial amount suffer from breast pain while running but ... the issue. , Zensah emphasizes the importance for ...

(Date:5/22/2013)... Angeles, CA (PRWEB) May 22, 2013 ... , hosted by Patricia O’Laughlin Psychotherapy in the ... seeing people of all ages as progression to ... children of all ages into parenting therapy has ... O’Laughlin emphasizes. Patricia O’Laughlin Psychotherapy now specializes in ...

(Date:5/22/2013)... Scottsdale, AZ (PRWEB) May 22, 2013 ... spend the next year participating in an intensive startup ... deliver valuable products or services and create local jobs ... . , Each year the Edson initiative offers approximately ... funding, office space, mentorship and training to launch their ...

[0] Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge [0] The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC [0] Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners [0] Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort

... The Partnership for Food Safety Education Tackles Four Common ... WASHINGTON, Aug. 26 Recipes can be ... food safety -- sometimes with sickening consequences. September is National ... (PFSE), in cooperation with the Food and Drug Administration, the Centers ...

... explain why many patients respond poorly to chemo ... -- Finnish researchers say they have identified a ... , The investigators used a three-dimensional imaging technique ... flow and glucose consumption -- a measure of ...

... , , HARRISBURG, Pa., Aug. 26 ... of Senator Kennedy of Massachusetts: , , "I was saddened ... the true giants of American public life. It marks the end of an ... , "During almost five decades in the United States Senate, Ted ...

... , , KANSAS CITY, Mo., Aug. 26 ... n cer Ce n ter ... which supports the nation,s foremost cancer treatment and research network, has treated its first patient ... its new KCCC-Shawnee Mission office. , , KCCC is the only ...

... ... ever-larger role in public relations practice, many PR professionals are turning to BurrellesLuce for valuable ... ... As social media assumes an ever-larger role in public relations practice, many PR professionals are ...

... LINO LAKES, Minn., Aug. 26 ... regional construction firms have been recognized by Minnesota Laborers-Employers Cooperation ... in 2008. , , Begun in 2007, ... safety performance and proactive approach of Skilled Construction Union Laborers ...

Cached Medicine News:Health News:MythBusters: Dishing Up Food Safety Fact From Fiction 2 Health News:MythBusters: Dishing Up Food Safety Fact From Fiction 3 Health News:Blood Flow Mismatch Seen in Pancreatic Cancers 2 Health News:New Precision Radiation Treatment System Fights Cancer 2 Health News:New Precision Radiation Treatment System Fights Cancer 3 Health News:PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 2 Health News:PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 3 Health News:Twenty-Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 2

MythBusters: Dishing Up Food Safety Fact From Fiction Blood Flow Mismatch Seen in Pancreatic Cancers Pennsylvania Governor Rendell Issues Statement on Senator Edward M. Kennedy New Precision Radiation Treatment System Fights Cancer PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce Twenty-Two Regional Construction Firms Recognized for Their Commitment to Worker Safety

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Promazine, Urine Prolactin Macroadenoma Prograf Proloprim